• LAST PRICE
    8.12
  • TODAY'S CHANGE (%)
    Trending Up0.03 (0.37%)
  • Bid / Lots
    8.11/ 77
  • Ask / Lots
    8.12/ 162
  • Open / Previous Close
    8.10 / 8.09
  • Day Range
    Low 8.08
    High 8.14
  • 52 Week Range
    Low 7.70
    High 8.95
  • Volume
    165,964
    above average
  • Overall Morningstar Rating
    Please Note: Not Ratedout of funds

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 8.09
TimeVolumeHHL
09:32 ET81008.1
09:35 ET10008.11
09:37 ET100008.11
09:39 ET8008.11
09:42 ET32008.13
09:55 ET31008.12
10:02 ET6008.13
10:04 ET1008.125
10:09 ET1008.125
10:11 ET9008.12
10:13 ET62008.125
10:15 ET5008.125
10:22 ET320008.135
10:24 ET4008.13
10:26 ET27008.13
10:27 ET3008.12
10:29 ET3008.115
10:40 ET19008.115
10:42 ET2008.115
10:44 ET24008.115
10:51 ET12008.115
10:54 ET1008.115
11:00 ET35008.115
11:02 ET26008.125
11:12 ET128008.115
11:16 ET12008.11
11:18 ET217008.11
11:23 ET8008.105
11:30 ET39008.11
11:32 ET74008.11
11:34 ET122008.105
11:39 ET4008.105
11:41 ET33008.105
11:45 ET15008.11
11:48 ET6008.105
11:52 ET109008.11
11:54 ET2008.12
11:59 ET52008.12
12:01 ET9008.12
Data delayed at least 15 minutes.
Asset Class
Asset Class
US Equity
90.3%
Int'l Equity
9.4%
Fixed Income
1.1%
CDN Equity
0
Other
0
Cash
-0.8%
Sectors
Sectors
Healthcare100.1%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
Geographic Region
United States
90.3%
Latin America
0
Africa
0
Asia/Oceania
0
Canada
0
Europe
0
As of 2024-10-31
Top 10 Holdings
Company Name sortablePosition sortableAllocation sortable
Allocation
1 Month Change
sortable
Market Value sortable
United StatesABBV
AbbVie Inc
Long
5.5%
+12.49%
$83.9M
United StatesBMY
Bristol-Myers Squibb Co
Long
5.4%
-6.51%
$82.7M
United StatesAMGN
Amgen Inc
Long
5.1%
+7.20%
$78.9M
United StatesDHR
Danaher Corp
Long
5.1%
+13.58%
$78.6M
United StatesUNH
UnitedHealth Group Inc
Long
5.1%
+3.12%
$77.8M
United StatesABT
Abbott Laboratories
Long
5.0%
-7.31%
$77.1M
United StatesSYK
Stryker Corp
Long
5.0%
-8.06%
$77.1M
United StatesTMO
Thermo Fisher Scientific Inc
Long
5.0%
+10.63%
$77.0M
United StatesJNJ
Johnson & Johnson
Long
5.0%
+0.09%
$77.0M
United StatesBSX
Boston Scientific Corp
Long
5.0%
-12.29%
$77.0M
As of 2024-11-22

Reports

No reports available

Morningstar Ratings

Morningstar Ratings Table
Time HorizonStar Rating
Overall RatingPlease Note: Not Rated
3 Year RatingPlease Note: Not Rated
5 Year RatingPlease Note: Not Rated
10 Year RatingPlease Note: Not Rated
As of 2024-10-31

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
---
Category
Sector Equity
Sponsor
Harvest Portfolios Group Inc.
Inception
December 18, 2014
As of 2024-10-31

The Fund's investment objective is to provide Unitholders with (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower overall volatility of portfolio returns than would otherwise be experienced by owning Equity Securities of the Healthcare Leaders directly. To achieve lower overall volatility of portfolio returns, the Fund will generally write covered call options on up to 33% of the portfolio securities. The level of covered call option writing may vary based on market volatility and other factors.

Holding Details
Total Net Assets$1.4B
Shares Out.168.8M
Net Asset Value (NAV)$8.09
Prem/Discount to NAV0.06%
P/E Ratio31.5
Dividend Yield8.70%
Dividend per Share0.71 CAD
Ex-Dividend Date10/31/2024
Dividend Payment Date11/8/2024
Beta---
Morningstar Investment StyleSector Equity
Equity Style
Large Cap Value
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.85%
Actual Mgmt. Expense Ratio (MER)0.99%